跳至主要内容
临床试验/NCT04500470
NCT04500470已完成不适用

Ketoprofen With or Without Vaginal Isonicotinic Acid Hydrazide (INH) Prior to Hysterosalpingography in Primarily Infertile Patients: a Randomized Controlled Trial

Aswan University Hospital1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2020年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
200
试验地点
1
主要终点
Intensity of pain

研究概览

简要总结

The aim of our study is to determine the efficacy of Ketoprofen with or without vaginal isonicotinic acid hydrazide on the pain scores during HSG.

详细描述

hysterosalpingography can cause pain and discomfort in several ways: Use of the tenaculum to grasp the cervix and straighten the uterus for proper insertion; trans-cervical actions including measuring uterine depth, inserting the cannula; and injection of the dye

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

double blind placebo randomized controlled trial

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • any patient came for Hysterosalpingography

排除标准

  • any patient has contraindication to HSG

研究组 & 干预措施

Group B

Placebo Comparator

patients will have of oral Ketoprofen 60 minutes before the procedure plus 3 table vaginal placebo by the patient 12 hours before the procedure

干预措施: Ketoprofen + placebo (Drug)

Group A

Experimental

patients will have of oral Ketoprofen 60 minutes before the procedure plus 3 table 900 mg vaginal isonicotinic acid hydrazide by the patient 12 hours before the procedure

干预措施: Ketoprofen + INH (Drug)

结局指标

主要结局

Intensity of pain

时间窗: 15 minutes

pain during the procedure assessed by the visual analog scale from 0=no pain to 10 = the worst pain imaginable

次要结局

  • Intensity of pain(30 minutes after the procedure)

研究者

发起方
Aswan University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

hany farouk

A Professor

Aswan University Hospital

研究点 (1)

Loading locations...

相似试验

Ketoprofen With or Without Vaginal Isonicotinic Acid... | 临床试验